Real-time fMRI Neurofeedback for Mild/Moderate Depression
NCT ID: NCT05025904
Last Updated: 2021-08-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
33 participants
INTERVENTIONAL
2017-06-06
2019-04-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Targeting Large-scale Networks in Depression With Real-time fMRI (Functional Magnetic Resonance Imaging) Neurofeedback
NCT05934604
Targeting Large-scale Networks in Depression With Real-time Functional Magnetic Resonance Imaging (fMRI) Neurofeedback
NCT06050070
Study Pilot - Hybrid EEG/fMRI Neurofeedback in Depressed Patients
NCT04450186
Neurofeedback as a Treatment Tool for Depression
NCT01544205
FMRI-neurofeedback in Depression
NCT05640089
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Real-time fMRI neurofeedback (rt-fMRI NFB)
The duration of a session was approximately a half-hour. The course duration was 8 sessions. The preferred frequency was once a week, however, the schedule was flexibly adjusted for patients' convenience.
Real-time fMRI neurofeedback (rt-fMRI NFB)
Real-time fMRI neurofeedback targeting control of the left medial prefrontal cortex. Participants continuously received visual feedback on the level of activity within the 2D region of interest corrected to the whole-slice brain volume activity. Up- and downregulation blocks were switched for better control.
Сognitive behavioral therapy (CBT)
The duration of a session was approximately an hour/hour and a half. The course duration was 8 individual and 8 group sessions and included home assignments. The preferred frequency was twice a week, however, the schedule was flexibly adjusted for patients' convenience and for improving benefits of the treatment.
Сognitive behavioral therapy (CBT)
A combination of individual and small-group cognitive behavioral therapy by an experienced medical psychologist and a psychiatrist.
EEG neurofeedback (EEG NFB)
The duration of a session was approximately a half-hour. The course duration was 16 sessions. The preferred frequency was twice a week, however, the schedule was flexibly adjusted for patients' convenience.
Group was preliminarily aborted for lack of time and participants in order to assign more patients to the abovementioned arms.
EEG neurofeedback (EEG NFB)
EEG neurofeedback targeting frontal alpha asymmetry index. Participants continuously received visual feedback on their frontal alpha asymmetry index. Up-regulation condition only was utilized.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Real-time fMRI neurofeedback (rt-fMRI NFB)
Real-time fMRI neurofeedback targeting control of the left medial prefrontal cortex. Participants continuously received visual feedback on the level of activity within the 2D region of interest corrected to the whole-slice brain volume activity. Up- and downregulation blocks were switched for better control.
Сognitive behavioral therapy (CBT)
A combination of individual and small-group cognitive behavioral therapy by an experienced medical psychologist and a psychiatrist.
EEG neurofeedback (EEG NFB)
EEG neurofeedback targeting frontal alpha asymmetry index. Participants continuously received visual feedback on their frontal alpha asymmetry index. Up-regulation condition only was utilized.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Sufficient self-regulation ability (verified with 3 sessions of ALAY EEG neurofeedback)
Exclusion Criteria
* Depression secondary to other mental or somatic conditions
* Psychotic features in depression or comorbid psychotic disorder
* Serious suicide risk
* Seasonal depression
* Receiving or planning to receive psychotropic medications
* Receiving cardiovascular medications
* General MRI exclusions
* Current pregnancy
* IQ\<70 (established with Raven's progressive matrices)
* Previous experience with neurofeedback
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal Research Center of Fundamental and Translational Medicine, Russian Federation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark B. Shtark, Ph.D.
Role: STUDY_DIRECTOR
FRC FTM
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Federal Reserch Center of Fundamental and Translational Medicine
Novosibirsk, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-15-00183
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.